Kayıkçıoglu, E., & Findos, E. (2022). The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide: Prognostic immune nutritional index and prostate adenocancer. The Injector, 1(3), 106–114. https://doi.org/10.5281/zenodo.7331456